Lomond Therapeutics Holdings, Inc. Quarterly Debt-to-equity in % from Q3 2022 to Q4 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Lomond Therapeutics Holdings, Inc. quarterly Debt-to-equity history and growth rate from Q3 2022 to Q4 2024.
Lomond Therapeutics Holdings, Inc. Debt-to-equity for the quarter ending December 31, 2024 was 25.2 %.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q4 2024	25.2	+44.4		Dec 31, 2024
Q3 2024	-21.2	-18.2	-593%	Sep 30, 2024
Q2 2024	-20.6	-18	-695%	Jun 30, 2024
Q1 2024	-20	-17.9	-871%	Mar 31, 2024
Q4 2023	-19.2	-17.7	-1199%	Dec 31, 2023
Q3 2023	-3.06	+111	+97.3%	Sep 30, 2023
Q2 2023	-2.59			Jun 30, 2023
Q1 2023	-2.06			Mar 31, 2023
Q4 2022	-1.48			Dec 31, 2022
Q3 2022	-114			Sep 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.